News & Updates
Showing Urology articles
Showing
Show Multimedia Only

OnabotulinumtoxinA as effective as, safer than pharmacotherapy for OAB
02 Oct 2025
byStephen Padilla
Women with refractory overactive bladder (OAB) may improve their symptoms by using either intradetrusor onabotulinumtoxinA or combined pharmacotherapy with solifenacin and mirabegron, suggests a study.
02 Oct 2025

Enzalutamide plus radium-223 improves rPFS in mCRPC
12 Sep 2025
byStephen Padilla
First-line treatment with enzalutamide plus radium-223 (Ra223) results in significant improvements in radiological progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC), results of the EORTC 1222/PEACE-3 trial have shown.
12 Sep 2025

Statin exposure associated with longer OS in apalutamide-treated patients with advanced prostate cancer
28 Aug 2025
byNatalia Reoutova
A study using individual patient data from the SPARTAN and TITAN randomized clinical trials has found that statin exposure was associated with superior overall survival (OS) among all patients with advanced prostate cancer (PC) who were treated with apalutamide.
28 Aug 2025





